All In MedTech

Device Trial Radar · NCT00678249

Pivotal Study for the FLAIR Endovascular Stent Graft

A Prospective, Multi-Center, Randomized Evaluation of an IMPRA/Bard ePTFE Encapsulated Carbon Lined Nitinol Endoluminal Device for AV Access Graft Stenoses

Last checked: Nov 20, 2026Latest source record: May 11, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingTitle says "pivotal". Randomized with 227 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

227

Actual

Start

Jan 2001

Primary completion

Jun 2004

Study completion Jun 2004

Sponsor

Lead sponsor
C. R. BardPublic (BDX)
Sponsor type
Industry
First posted
May 15, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study compared the FLAIR™ Endovascular Stent Graft to balloon angioplasty in patients with stenoses at the venous anastomosis of a synthetic AV access graft.

Conditions

  • Stenoses

Interventions

  • FLAIR Endovascular Stent GraftDevice

    Primary balloon angioplasty followed by placement of the FLAIR Endovascular Stent Graft

  • PTAProcedure

    Percutaneous Transluminal Angioplasty

  • FLAIR Endovascular Stent GraftDevice

    Primary PTA followed by placement of the FLAIR Endovascular Stent Graft. Roll-in participants were enrolled in the study for training purposes and were not randomized.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent of Participants With Treatment Area Primary Patency (TAPP)Time frame: 6 month follow-up

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • New York Presbyterian Hospital/Columbia

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.